News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Colorado Founder Of Stevens Johnson Syndrome Foundation Will Join 7-Year-Old SJS Victim At Washington, D.C., Press Conference
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
--(BUSINESS WIRE)-- -- They Seek the FDA's Help in Reinstating a Warning Label on Children's Motrin About SJS -- Jean McCawley of the SJS Foundation Will Discuss Dramatic Rise in Reported SJS Cases in Children
Twitter
LinkedIn
Facebook
Email
Print
Events
MORE ON THIS TOPIC
gene therapy
Advanced Therapies Week 2026: ‘Solving for Science’ and Weathering Global Complexity
January 28, 2026
·
4 min read
·
Heather McKenzie
FDA
JPM26: Beam, Cabaletta, More Zero In on Regulatory Alignment After Tumultuous Year
January 19, 2026
·
6 min read
·
Heather McKenzie
Business
JPM26 Day 2: Companies Lay Out Near-Term Revenue, Longer-Term Business Goals
January 14, 2026
·
4 min read
·
Tristan Manalac
obesity
JPM26: Novartis Doesn’t Have a GLP-1. They Don’t Miss It In a World Of Me-Toos
January 13, 2026
·
3 min read
·
Annalee Armstrong